Advertisement

Select an AACR Journal

Select an AACR Journal

Select an AACR Journal

From molecules to medicine, from proteomics to prevention, the journals of the AACR cover the entire spectrum of cancer research. Please select the journal that is most appropriate for your manuscript and follow the instructions to access the correct submission system.

Blood Cancer Discovery will provide a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Studies published in Blood Cancer Discovery will describe mechanisms underlying disease biology; diagnostic and therapeutic development; and translation of these data into clinical trials.

»»  Submit a Manuscript to Blood Cancer Discovery

Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials. As the premier cancer information resource, the Journal also presents Review Articles, Perspectives and Commentaries, News stories, and Research Watch summaries of important journal articles to its readers to keep them informed about the latest findings in the field. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic and epidemiologic studies.

»»  Submit a Manuscript to Cancer Discovery

Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.

»»  Submit a Manuscript to Cancer Epidemiology, Biomarkers & Prevention

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.

Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.

»»  Submit a Manuscript to Cancer Immunology Research

Cancer Prevention Research is devoted exclusively to cancer prevention. The Journal publishes important original studies, reviews, and perspectives within the major topic areas of biology of premalignancy, risk factors and risk assessment, early detection research, immunoprevention, and chemopreventive and other interventions, including the basic science behind them. Cancer Prevention Research comprises preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

»»  Submit a Manuscript to Cancer Prevention Research

Cancer Research publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the journal is captured in its primary subsections: Genome and Epigenome, Metabolism and Chemical Biology, Molecular Cell Biology, Tumor Biology and Immunology, Translational Science, Convergence and Technologies, and Population and Prevention Science.

»»  Submit a Manuscript to Cancer Research

Cancer Research Communications — an open access journal, encourages high-quality submissions from all areas of cancer science and medicine. Submissions are welcome that advance basic, translational, or clinical cancer research in the following subdisciplines: Molecular and Cellular Biology, Tumor Biology, Immuno-oncology, Therapeutic Research and Development, Emerging Technologies and Data Science, Precision Medicine and Biomarkers, Clinical Research and Trials, Epidemiology and Prevention, and Health Disparities and Outcomes Research.

»»  Submit a Manuscript to Cancer Research Communications

Clinical Cancer Research — A Journal of Clinical and Translational Research — focuses on innovative clinical research and translational research that bridges the laboratory and the clinic. Clinical Cancer Researchpresents clinical trials evaluating new treatments for cancer; research on molecular abnormalities that predict incidence, response to therapy, and outcome; and laboratory studies of new drugs and biomarkers that will lead to clinical trials in patients.

»»  Submit a Manuscript to Clinical Cancer Research

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the Journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; and signal transduction), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.

»»  Submit a Manuscript to Molecular Cancer Research

Molecular Cancer Therapeutics — Integrating Targets, Therapeutics, and Technologies — strives to be the top choice for publishing the best science in the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanisms of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms. While the Journal's main focus is on small molecule and protein drugs, other molecular entities may be considered.

»»  Submit a Manuscript to Molecular Cancer Therapeutics

 

American Association for Cancer Research
615 Chestnut Street  |  17th Floor  |  Philadelphia, PA 19106-4404
Phone: (215) 440-9300  |  Fax: (215) 440-9354  |  E-mail:  pubs@aacr.org